Tag Archives: Dr Francisco Westermeier

Research: Epstein-Barr Virus in ME/CFS

Posted on 08/01/2022 by wames

Revisiting IgG antibody reactivity to Epstein-Barr Virus in Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome and its potential application to disease diagnosis Key research findings: Epstein-Barr virus (EBV) infection is commonly reported at the onset of ME/CFS, but could antibodies against EBV … Continue reading →

Posted in News | Tagged , , , , , , , , , , , , , | Comments Off on Research: Epstein-Barr Virus in ME/CFS

Research review: Unknown aetiology: The case of ME/CFS and beyond

Posted on 03/02/2022 by wames

Current insights into complex Post-infection Fatigue Syndromes with unknown Aetiology: The case of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and beyond, by Francisco Westermeier, Eliana Mattos Lacerda,  Carmen Scheibenbogen and  Nuno Sepúlveda in Front. Med., 24 February 2022 [doi.org/10.3389/fmed.2022.862953]   Excerpts from … Continue reading →

Posted in News | Tagged , , , , , , , , , , | Comments Off on Research review: Unknown aetiology: The case of ME/CFS and beyond

Research: Decreased NO production in endothelial cells… from ME/CFS patients

Posted on 02/18/2022 by wames

Decreased NO production in endothelial cells exposed to plasma from ME/CFS patients, by R Bertinat, RVillalobos-Labra, L Hofmann, J Blauensteiner, N Sepúlveda, F Westermeir in Vascular Pharmacology 2022, 106953 [doi.org/10.1016/j.vph.2022.106953]   Highlights ME/CFS-plasma reduced the ability of ECs to produce NO. … Continue reading →

Posted in News | Tagged , , , , , , , , | Comments Off on Research: Decreased NO production in endothelial cells… from ME/CFS patients